Umbilical cord blood (UCB) cells have been definitively proved to be a source of hematopoietic stem cells with repopulating capacity when transplanted into pediatric hosts with neoplastic or non-neoplastic disease. Moreover, due to the immaturity of the UCB lymphoid compartment, these transplants are usually associated with a low incidence and severity of GvHD. This clinical observation and the immaturity of the UCB lymphoid compartment justify the acceptance of UCB units which differ from their recipient by 1 or 2 HLA antigens of the six HLA A, B and DRB1 antigens conventionally typed. Whether the number and type of HLA disparities affect clinical outcome of UCB transplants has not, however, been clearly demonstrated yet
AbstractUmbilical cord blood hematopoietic stem cells coming from related or unrelated donors are an...
Unrelated cord blood transplantation (UCBT) provides a curative therapy for patients with hematologi...
We studied the effect of allele-level matching at human leukocyte antigen (HLA)-A, -B, -C, and -DRB1...
Umbilical cord blood (UCB) cells have been definitively proved to be a source of hematopoietic stem ...
Hematopoietic stem cell transplantation is currently used as a curative treatment for patients with ...
AbstractAn analysis of NMDP data shows that allele-level matching for HLA A, B, C, and DRB1 is prefe...
Umbilical cord blood (UCB) transplantation has been consistently found to have low rates of graft-ve...
HLA compatibility is a significant factor in clinical allogeneic marrow transplantation. Disparity f...
HLA matching is a critical determinant of outcomes for patients who have undergone umbilical cord bl...
Allogeneic haematopoietic SCT is a standard therapy for many patients with haematological diseases. ...
HLA matching is a critical determinant of outcomes for patients who have undergone umbilical cord bl...
Umbilical cord blood transplantation (UCBT) is becoming a salvage treatment in lieu of bone marrow o...
Ten consecutive children with high risk leukemia have been submitted to UCB transplant from unrelate...
Umbilical cord blood (UCB) from an human leucocyte antigen (HLA)-identical sibling can be used for t...
Ten consecutive children with high risk leukemia have been submitted to UCB transplant from unrelate...
AbstractUmbilical cord blood hematopoietic stem cells coming from related or unrelated donors are an...
Unrelated cord blood transplantation (UCBT) provides a curative therapy for patients with hematologi...
We studied the effect of allele-level matching at human leukocyte antigen (HLA)-A, -B, -C, and -DRB1...
Umbilical cord blood (UCB) cells have been definitively proved to be a source of hematopoietic stem ...
Hematopoietic stem cell transplantation is currently used as a curative treatment for patients with ...
AbstractAn analysis of NMDP data shows that allele-level matching for HLA A, B, C, and DRB1 is prefe...
Umbilical cord blood (UCB) transplantation has been consistently found to have low rates of graft-ve...
HLA compatibility is a significant factor in clinical allogeneic marrow transplantation. Disparity f...
HLA matching is a critical determinant of outcomes for patients who have undergone umbilical cord bl...
Allogeneic haematopoietic SCT is a standard therapy for many patients with haematological diseases. ...
HLA matching is a critical determinant of outcomes for patients who have undergone umbilical cord bl...
Umbilical cord blood transplantation (UCBT) is becoming a salvage treatment in lieu of bone marrow o...
Ten consecutive children with high risk leukemia have been submitted to UCB transplant from unrelate...
Umbilical cord blood (UCB) from an human leucocyte antigen (HLA)-identical sibling can be used for t...
Ten consecutive children with high risk leukemia have been submitted to UCB transplant from unrelate...
AbstractUmbilical cord blood hematopoietic stem cells coming from related or unrelated donors are an...
Unrelated cord blood transplantation (UCBT) provides a curative therapy for patients with hematologi...
We studied the effect of allele-level matching at human leukocyte antigen (HLA)-A, -B, -C, and -DRB1...